Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-2,206
Closed -$227K – 109
2023
Q3
$227K Buy
+2,206
New +$238K 0.06% 97
2023
Q1
– Sell
-2,201
Closed -$244K – 128
2022
Q4
$244K Buy
+2,201
New +$225K 0.09% 100
2022
Q2
– Sell
-3,576
Closed -$293K – 124
2022
Q1
$293K Sell
3,576
-1,248
-26% -$98.4K 0.09% 91
2021
Q4
$370K Buy
+4,824
New +$384K 0.11% 77
2021
Q2
$346K Buy
+4,443
New +$330K 0.13% 74

Other funds holding MRK

Rollins Financial's MRK Position: Q4 2023 in Review

Rollins Financial sold out of Merck (MRK) in Q4 2023, closing a stake of 2,206 shares — an estimated $227K sold.

Rollins Financial first reported a position in MRK in Q2 2021 and held it in 5 quarters. The position peaked at $370K in Q4 2021. 3,439 funds tracked by Wall St. Rank hold MRK as of Q4 2023.

  • Rollins Financial reported no remaining Merck position as of Q4 2023 after selling out during the quarter.
  • Rollins Financial sold 2,206 Merck shares in Q4 2023, an estimated $227K.
  • Rollins Financial first reported a position in Merck in Q2 2021 and held it in 5 quarters.
  • Rollins Financial's Merck position peaked at $370K in Q4 2021.
  • 3,439 funds tracked by Wall St. Rank held Merck as of Q4 2023.

Based on Rollins Financial's 13F filing for Q4 2023, filed 6 Feb 2024.